Skip to main content
RUNBEN BIOTECHNOLOGY CO., LTD. logo

RUNBEN BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603193 ISIN · CNE100006DK5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603193

About RUNBEN BIOTECHNOLOGY CO., LTD.

https://www.runben.com/

Runben Biotechnology Co., Ltd. focuses on the research, development, production, and distribution of personal care and household hygiene solutions. The company’s core product portfolio is categorized into mosquito repellents, infant and child care, and essential oil products. Key offerings include electric mosquito repellent liquids, botanical essential oil patches, and specialized skincare items such as moisturizing creams and cleansing products tailored for sensitive skin. Runben prioritizes the integration of biotechnology with natural formulations to ensure product safety and efficacy. By maintaining a strong emphasis on product innovation and quality control, the company serves a broad consumer base through integrated online and offline sales channels, positioning itself as a provider of health-oriented daily necessities for family environments.

Recent filings

Filing Released Lang Actions
2025年年度股东会会议资料
Regulatory Filings
2026-05-07 Chinese
关于2026年第一季度主要经营数据的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company disclosing its main operating data for the first quarter of 2026, including production, sales volume, revenue, and price changes of products and raw materials. It is explicitly titled as an announcement of quarterly main operating data, not a full interim or quarterly financial report. The document length is short (1632 characters) and contains summary data without detailed financial statements or comprehensive analysis. It fits the profile of a regulatory announcement of operating data rather than a full Interim/Quarterly Report (IR). Therefore, the best classification is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2026-04-22 Chinese
关于2026年度使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 润本生物技术股份有限公司 regarding the use of idle self-owned funds for cash management by investing in low-risk financial products. It details the investment amount, purpose, risk analysis, and approval procedures. The document is relatively short (1771 characters) and does not contain any financial statements or detailed financial data. It is an update on capital management activities rather than a full financial report or earnings release. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including cash management and investment of idle funds.
2026-04-22 Chinese
第二届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 12th meeting of the 2nd Board of Directors of Runben Biotechnology Co., Ltd. It includes multiple agenda items such as approval of the 2025 Annual Report and summary, profit distribution plan, board work report, independent directors' reports, internal control evaluation report, audit firm evaluation, remuneration management system, and approval of the 2026 Q1 report, among others. The document repeatedly states that the detailed reports are disclosed separately on the Shanghai Stock Exchange website and that these resolutions will be submitted to the 2025 Annual General Meeting for approval. The document is a formal board meeting resolution announcement, not the actual annual report or financial report itself. It is a typical Board/Management Information announcement about board meeting decisions and approvals. Therefore, the correct classification is MANG (Board/Management Information). The document length (4658 characters) and content support this classification with high confidence.
2026-04-22 Chinese
2026年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2026年第一季度报告" which translates to "2026 First Quarter Report". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2026. The report explicitly states it is unaudited and covers a period shorter than a full fiscal year (quarterly). The content includes comprehensive financial statements and analysis typical of an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, and the document length (13,217 characters) supports it being a full report rather than a brief announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-04-22 Chinese
董事、高级管理人员2025年度薪酬发放情况及2026年度薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the remuneration (salary) of the company's directors and senior management for the year 2025 and the remuneration plan for 2026. It details the salary structure, payment principles, and related policies. It references the 2025 annual report for detailed remuneration information but does not contain the full remuneration report itself. The document is a formal announcement about remuneration information rather than a full compensation report or proxy statement. Therefore, it fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-04-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.